Credit Suisse Group reiterated their positive rating on shares of Align Technology, Inc. (NASDAQ:ALGN) in a research note released on Thursday morning, The Fly reports. The firm currently has a $261.00 price objective on the medical equipment provider’s stock, up from their prior price objective of $209.00.

ALGN has been the subject of several other reports. Stifel Nicolaus reaffirmed a buy rating and set a $225.00 price objective (up from $205.00) on shares of Align Technology in a research note on Thursday, October 19th. Northcoast Research reaffirmed a buy rating and set a $230.00 price objective (up from $200.00) on shares of Align Technology in a research note on Tuesday, October 10th. Bank of America Corporation raised shares of Align Technology from a neutral rating to a buy rating and upped their price objective for the company from $175.00 to $193.00 in a research note on Friday, July 28th. Zacks Investment Research raised shares of Align Technology from a hold rating to a buy rating and set a $227.00 price objective for the company in a research note on Monday, October 30th. Finally, Robert W. Baird reaffirmed a buy rating on shares of Align Technology in a research note on Tuesday, September 12th. Eleven analysts have rated the stock with a buy rating, The stock presently has an average rating of Buy and an average target price of $219.18.

Align Technology (NASDAQ:ALGN) traded down $0.17 during midday trading on Thursday, reaching $249.46. 927,500 shares of the company’s stock traded hands, compared to its average volume of 1,295,819. The stock has a market capitalization of $20,001.21, a price-to-earnings ratio of 73.80, a price-to-earnings-growth ratio of 2.39 and a beta of 1.42. Align Technology has a twelve month low of $88.56 and a twelve month high of $254.19.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings data on Thursday, October 26th. The medical equipment provider reported $1.01 EPS for the quarter, beating the consensus estimate of $0.82 by $0.19. The firm had revenue of $385.30 million during the quarter, compared to the consensus estimate of $359.80 million. Align Technology had a net margin of 19.98% and a return on equity of 25.60%. The company’s quarterly revenue was up 38.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.63 earnings per share. equities research analysts forecast that Align Technology will post 3.62 earnings per share for the current year.

WARNING: “Align Technology, Inc. (ALGN) Earns “Positive” Rating from Credit Suisse Group” was reported by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/11/12/align-technology-inc-algn-earns-positive-rating-from-credit-suisse-group.html.

In related news, CMO Raphael Pascaud sold 5,400 shares of the stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $241.88, for a total value of $1,306,152.00. Following the completion of the transaction, the chief marketing officer now directly owns 22,228 shares of the company’s stock, valued at $5,376,508.64. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Greg J. Santora sold 7,700 shares of the stock in a transaction dated Tuesday, October 31st. The stock was sold at an average price of $238.95, for a total transaction of $1,839,915.00. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

A number of hedge funds have recently added to or reduced their stakes in the stock. Zeke Capital Advisors LLC bought a new position in Align Technology in the third quarter worth about $318,000. Dai Ichi Life Insurance Company Ltd bought a new position in shares of Align Technology during the third quarter valued at approximately $211,000. Axiom International Investors LLC DE bought a new position in shares of Align Technology during the third quarter valued at approximately $27,525,000. Schroder Investment Management Group increased its stake in shares of Align Technology by 242.9% during the third quarter. Schroder Investment Management Group now owns 2,400 shares of the medical equipment provider’s stock valued at $439,000 after purchasing an additional 1,700 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in shares of Align Technology by 4.6% during the third quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,867 shares of the medical equipment provider’s stock valued at $1,093,000 after purchasing an additional 257 shares in the last quarter. 81.16% of the stock is owned by institutional investors.

About Align Technology

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

The Fly

Analyst Recommendations for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.